This content is machine translated Chronic rhinosinusitis with nasal polyposis (CRSwNP) Criteria-driven use of biologics Typical symptoms of chronic rhinosinusitis with nasal polyps (CRSwNP) are obstructed nasal breathing, secretions, facial pain and olfactory disturbances. If adequate therapy is not provided, there is a risk of…
View Post 6 min This content is machine translated Chronic rhinosinusitis Endotyping as a basis for targeted treatment In particular, chronic rhinosinusitis with polyposis nasi (CRSwNP) is often associated with high levels of distress and personalized therapeutic strategies are required. Improved understanding of the immunological and inflammatory genesis…
View Post 3 min This content is machine translated Biologics in CRSwNP Equal opportunity and challenge For ENT physicians in private practice, the approval of biologics for the indication of chronic rhinosinusitis with polyposis nasi (CRSwNP) means on the one hand an expansion of treatment options.…
View Post 4 min This content is machine translated Upper respiratory tract comorbidities When asthma and rhinosinusitis go hand in hand Almost half (45%) of all patients with – mainly severe – asthma are also affected by chronic rhinosinusitis with nasal polyps (CRSwNP). As many as 60% have allergic rhinitis as a…
View Post 15 min This content is machine translated Asthma therapy The mild bronchial asthma Bronchial asthma is a heterogeneous, multifactorial disease characterized by chronic airway inflammation and bronchial hyperresponsiveness. Not only the symptomatology, but also the airway obstruction is variable in time course and… CME-Test
View Post 15 min This content is machine translated Asthma therapy The mild bronchial asthma Bronchial asthma is a heterogeneous, multifactorial disease characterized by chronic airway inflammation and bronchial hyperresponsiveness. Not only the symptomatology, but also the airway obstruction is variable in time course and…
View Post 4 min This content is machine translated Perspectives for CRSwNP therapy. New approaches in the pipeline Currently, there are two approved biologics for the treatment of CRS and polyposis nasi: dupilumab and omalizumab. However, several other therapeutic options are currently in development, some of which are…
View Post 5 min This content is machine translated Chronic rhinosinusitis The right nose with biologics Rhinosinusitis is divided into two groups: chronic with nasal polyps (CRSwNP) and those without (CRSsNP). It is a common disease, affecting about 11% of the population throughout Europe. Therapeutic options…
